
fiercebiotech.com
Apr 3, 2025, 18:28
Dr. Steven O’Day Discusses Innovations in Immunotherapy for Colorectal Cancer on “The Top Line” by Fierce Biotech – Agenus
Agenus shared on LinkedIn:
“Tune in to ‘The Top Line’ by Fierce Biotech! Our Chief Medical Officer, Dr. Steven O’Day, shares his insights on the latest innovations and the future of immunotherapy in colorectal cancer care.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 3, 2025, 17:06
Apr 3, 2025, 16:56
Apr 3, 2025, 16:37
Apr 3, 2025, 16:04